Search Results - "LIGHTFOOT, S. A"

Refine Results
  1. 1

    Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation by Smith, B.J., Lerner, M.R., Bu, S.Y., Lucas, E.A., Hanas, J.S., Lightfoot, S.A., Postier, R.G., Bronze, M.S., Brackett, D.J.

    Published in Bone (New York, N.Y.) (01-03-2006)
    “…Clinically, osteopenia or low bone mass has been observed in a variety of chronic inflammatory diseases, and elevated proinflammatory mediators have implicated…”
    Get full text
    Journal Article
  2. 2

    Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway by Franklin, M., Bu, S.Y., Lerner, M.R., Lancaster, E.A., Bellmer, D., Marlow, D., Lightfoot, S.A., Arjmandi, B.H., Brackett, D.J., Lucas, E.A., Smith, B.J.

    Published in Bone (New York, N.Y.) (01-12-2006)
    “…Previously, dietary supplementation with dried plums, a rich source of polyphenolic compounds with antioxidant and anti-inflammatory properties, has been shown…”
    Get full text
    Journal Article
  3. 3

    Therapeutic treatment of DMBA-induced mammary tumors with PPAR ligands by Pighetti, G M, Novosad, W, Nicholson, C, Hitt, D C, Hansens, C, Hollingsworth, A B, Lerner, M L, Brackett, D, Lightfoot, S A, Gimble, J M

    Published in Anticancer research (01-03-2001)
    “…The objective of this study was to evaluate the ability of troglitazone (a thiazolidinedione) and Wy-14,643 (a clofibrate) to inhibit progression of…”
    Get more information
    Journal Article
  4. 4

    Impaired glucose tolerance attenuates bone accrual by promoting the maturation of osteoblasts: Role of Beclin1-mediated autophagy by Rendina-Ruedy, E, Graef, J L, Lightfoot, S A, Ritchey, J W, Clarke, S L, Lucas, E A, Smith, B J

    Published in Bone Reports (01-12-2016)
    “…Patients with type 2 diabetes mellitus (T2DM) experience a 1.5-3.5 fold increase in fracture risk, but the mechanisms responsible for these alterations in bone…”
    Get full text
    Journal Article
  5. 5

    Stress induced in heart and other tissues by rat dermal exposure to JP-8 fuel by Larabee, J L, Hocker, J R, Lerner, M R, Lightfoot, S A, Cheung, J Y, Brackett, D J, Gallucci, R M, Hanas, J S

    Published in Cell biology and toxicology (01-09-2005)
    “…Limited information is available regarding the development of systemic organ stress by dermal exposure to JP-8 fuel. In this study, the systemic stress…”
    Get full text
    Journal Article
  6. 6

    Involvement of capsaicin-sensitive sensory neurons in stress-induced gastroduodenal mucosal injury in rats by JIAYUAN REN, JIESHENG GAO, OJEAS, H, LIGHTFOOT, S. A, KIDA, M, BREWER, K, HARTY, R. F

    Published in Digestive diseases and sciences (01-04-2000)
    “…The pathogenesis of stress-induced gastroduodenal mucosal injury is complex and incompletely understood. The aim of this investigation was to examine the…”
    Get full text
    Journal Article
  7. 7

    Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen by HOLLINGSWORTH, A. B, LERNER, M. R, LIGHTFOOT, S. A, WILKERSON, K. B, HANAS, J. S, MCCAY, P. B, BRACKETT, D. J

    “…Leuprolide, a gonadotropin releasing hormone agonist, is currently being evaluated in a pilot study of premenopausal women for the prevention of breast cancer…”
    Get full text
    Journal Article
  8. 8

    Biological Assay for Activity and Molecular Mechanism of Retinoids in Cervical Tumor Cells by Benbrook, Doris M., Lu, Shennan, Flanagan, Cole, Shen-Gunther, Jane, Angros, Lee H., Lightfoot, Stan A.

    Published in Gynecologic oncology (01-07-1997)
    “…The composition and response of the retinoid signaling pathway in a human cell line (CC-1), representative of a low grade cervical carcinoma, were evaluated…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Prevention of rat mammary carcinoma utilizing leuprolide as an equivalent to oophorectomy by JETT, E. A, LERNER, M. R, LIGHTFOOT, S. A, HANAS, J. S, BRACKETT, D. J, HOLLINGSWORTH, A. B

    Published in Breast cancer research and treatment (01-11-1999)
    “…A clinical trial is currently under way to examine the effectiveness of leuprolide as a breast cancer chemopreventive agent and contraceptive. This trial, as…”
    Get full text
    Journal Article
  10. 10

    113 T-REGULATORY CELL POOL IN PATIENTS WITH PANCREATIC CANCER by Bova, A. R., Holter, J. L., Li, Q., Lerner, M. R., Lightfoot, S. A., Brackett, D. J., Postier, R.

    Published in Journal of investigative medicine (01-01-2007)
    “…PurposeA subset of T cells essential for inhibitory properties such as self-tolerance termed regulatory T cells (Treg) has recently been described in patients…”
    Get full text
    Journal Article
  11. 11

    Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus by Hanas, J S, Lerner, M R, Lightfoot, S A, Raczkowski, C, Kastens, D J, Brackett, D J, Postier, R G

    Published in Cancer (01-09-1999)
    “…Barrett esophagus predisposes individuals to esophageal carcinoma, which develops from intermediate stages of tissue dysplasia primarily in the vicinity of the…”
    Get full text
    Journal Article
  12. 12

    Expression of Peroxisome Proliferator Activated Receptor mRNA in Normal and Tumorigenic Rodent Mammary Glands by Gimble, Jeffrey M., Pighetti, Gina M., Lerner, Megan R., Wu, Xiying, Lightfoot, Stan A., Brackett, Daniel J., Darcy, Kathleen, Hollingsworth, Alan B.

    “…The peroxisome proliferator activated receptors (PPARs) α, β/δ, and γ are novel nuclear hormone receptors activated by long chain fatty acids and synthetic…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20